European Commission launches consultation on nanotech safety
This article was originally published in RAJ Devices
Executive Summary
The European Commission’s Directorate General for Health is set to launch a public consultation on safety issues related to nanotechnology1. Results from the consultation will be used to help structure a one-day scientific hearing, set to take place on 10 September. The hearing will also focus, among other things, on the content of the recent opinion on the risk assessment of nanomaterials, published by the commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)2,3.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.